GE launches compact automated purification system

By Dan Stanton

- Last updated on GMT

GE launches compact automated purification system

Related tags: Ge healthcare life, Protein, Chromatography, Ge

GE Healthcare has launched an automated protein purification system it says can save researchers and labs time and decrease the risk of manual error. 

“The purification step is crucial in biomanufacturing, as regulated products in particular are required to reach a defined level of purity,”​ GE Healthcare Life Sciences spokesperson Nina Forsberg told Biopharma-Reporter.com.

However, she continued, “manual approaches are time-consuming and repetitive. One needs to stand over and operate the column, meaning valuable time is spent doing routine work. Manual collection of fractions and subsequent UV analysis also add to the hands-on time required to run a column.”

Furthermore, “manual handling means an increased risk of manual error,”​ she added and thus GE’s new Äkta start protein purification system offers a number of advantages, specifically for researchers and laboratories looking to make the move into automated purification.

There is currently an automated purification product - Äkta avant - that GE makes to support manufacturers and large-scale production, but the Äkta start is targeted in the first instance at scientists in research, Forsberg added, with a size and price to reflect this.

Whilst there are similar products available, Forsberg told us GE has “been at the cutting edge of chromatography systems since the first ÄKTA system was launched in 1996.

“The ÄKTA start system is built to the same exacting standards as the other ÄKTA systems, but is designed for simplicity of use and as an easy introduction to automated chromatography.”

Furthermore she told us “the system comes with inbuilt templates for common chromatography techniques such as affinity, gel filtration and ion-exchange, but also allows users to customise protocols to meet their needs.”

Related news

Show more

Related products

show more

Connectivity & Integration in Biomanufacturing

Connectivity & Integration in Biomanufacturing

Wheeler Bio | 17-Nov-2022 | Technical / White Paper

As the Pharma 4.0 initiative sets a new industry paradigm, more biomanufacturing companies are asking how they can design and build facilities that apply...

GMP manufacturing of buffers and liquid blends

GMP manufacturing of buffers and liquid blends

Actylis – The Partner of Choice | 16-Nov-2022 | Technical / White Paper

Actylis manufactures buffers, process solutions, cleaning solutions, Water for Injection (WFI) for further processing, and custom liquid blends in compliance...

Custom manufacturing of protease inhibitor PMSF

Custom manufacturing of protease inhibitor PMSF

Actylis – The Partner of Choice | 09-Nov-2022 | Technical / White Paper

By combining 75+ years of manufacturing and sourcing expertise, Actylis provides a wide portfolio of GMP ingredients to the pharma & biopharma market,...

Scalability, Quality, and Speed with Transposons

Scalability, Quality, and Speed with Transposons

Wheeler Bio | 20-Oct-2022 | Technical / White Paper

To solve for the significant bottlenecks often presented by conventional cell line development processes, this article discusses how Wheeler Bio is leveraging...

Related suppliers